New Delhi, Dec. 4 -- India has transformed from a medicine importer into a global generics powerhouse in the last five decades producing over 60,000 generic drugs across over 60 therapeutic categories and exporting to over 200 countries, according to the India Future Readiness Indicator (IFRI) 2025 report released by IMD in partnership with the Confederation of Indian Industry (CII).

The sector now contributes 1.7% of GDP and nearly 6% of merchandise exports, with a domestic valuation of approximately $55 billion, it highlighted.

The report mentioned that India's pharmaceutical industry is entering a decisive new phase marked by tighter supply chains, sustainable manufacturing pressures and an accelerated global shift toward advanced bi...